Watch as the speakers explore the role cfHPV-DNA plays in cancer prognosis, and what barriers biopharma companies face in incorporating cfHPV-DNA into their clinical trial design. The speakers discuss how pharma manufacturers, HCPs and patients can collaborate to help overcome these barriers.
![cfHPV-DNA webinar speakers](https://sysmex-inostics.com/wp-content/uploads/2024/02/HPV-Webinar-SII-People-1.jpg)